NCT05351606View on ClinicalTrials.gov

Integrating Tobacco Use Cessation Into HIV Care and Treatment in Kisumu County, Kenya

PHASE4CompletedINTERVENTIONAL
Enrollment

580

Participants

Timeline

Start Date

May 16, 2023

Primary Completion Date

January 7, 2025

Study Completion Date

January 7, 2025

Conditions
Tobacco Use CessationTobacco Use
Interventions
BEHAVIORAL

Tobacco Use Cessation Counselling Sessions

Counseling sessions will be given in person

DRUG

Bupropion

Given orally

DRUG

Nicotine patch

Given transdermally

DRUG

Nicotine lozenge

Given orally

Trial Locations (1)

40100

Kenya Medical Research Institute (KEMRI), Kisumu

Sponsors
All Listed Sponsors
collaborator

Kenya Medical Research Institute

OTHER

collaborator

National Cancer Institute (NCI)

NIH

lead

University of California, San Francisco

OTHER